2017
DOI: 10.1016/j.eurpolymj.2016.10.041
|View full text |Cite
|
Sign up to set email alerts
|

POxylation as an alternative stealth coating for biomedical applications

Abstract: Polyethylene glycol (PEG) polymers are currently used in a variety of medical formulations to reduce toxicity, minimize immune interactions and improve pharmacokinetics. Despite its widespread use however, the presence of anti-PEG antibodies indicates that this polymer has the potential to be immunogenic and antigenic. Here we present an alternative polymer, poly(2-oxazoline) (POx) for stealth applications, specifically shielding of a proteinaceous nanoparticle from recognition by the immune system. Tobacco mo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
58
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 87 publications
(62 citation statements)
references
References 45 publications
0
58
0
Order By: Relevance
“…Although this group did not perform circulation studies they did investigate their nanogels for induced hemolysis and erythrocyte aggregation and found no significant interaction of the nanogels with blood. Other recent studies on PEtOx modified nanoparticles and PMeOx coated viruses, each without the ability to vary the zeta potential, similarly found reduced interaction of PAOx modified materials with cells.…”
Section: Emerging Applicationsmentioning
confidence: 71%
“…Although this group did not perform circulation studies they did investigate their nanogels for induced hemolysis and erythrocyte aggregation and found no significant interaction of the nanogels with blood. Other recent studies on PEtOx modified nanoparticles and PMeOx coated viruses, each without the ability to vary the zeta potential, similarly found reduced interaction of PAOx modified materials with cells.…”
Section: Emerging Applicationsmentioning
confidence: 71%
“…chemotherapy delivery). To some extent, pharmacokinetics and immunogenicity of VNPs can be tailored through conjugation of a polymer stealth coating such as polyethylene glycol or polyoxazoline [18,50] or a camouflage coating such as albumin [51]. Yet newer and more modern approaches are required to make an impact in the clinic.…”
Section: Resultsmentioning
confidence: 99%
“…2838 Nevertheless, as chemistries and products are being made available to wider audiences, the risk exists that these polymers are also formulated into everyday products thus leading to generation of acquired immunity against them. Furthermore, as pointed out above, the risk also exists that patients could develop antibodies after repeated exposure, as has been observed for PEG.…”
Section: Peg and Other Synthetic Polymeric Shielding Strategiesmentioning
confidence: 99%